Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Relations CareersResearchLicensingThe Merck Manuals

The Merck Manual of Geriatrics logo
red line
click here to go to the Contents page of The Merck Manual of Geriatrics
click here to go to the Title Page of The Merck Manual of Geriatrics
click here to search The Merck Manual of Geriatrics
you are at the Index of The Merck Manual of Geriatrics
red line
 
Index
Index A | Index B | Index C | Index D | Index E | Index F | Index G | Index H | Index I | Index J | Index K | Index L | Index M | Index N | Index O | Index P | Index Q | Index R | Index S | Index T | Index U | Index V | Index W | Index X,Y,Z

red line

Index H

HACEK infection, in endocarditis 880, 884t
Hachinski Ischemic Score 370t
Haemophilus influenzae infection 759, 762t
Hair
age-related changes in 656t, 1234-1235
excessive 1235
Halcinonide 1247t
Hallpike maneuver 188, 193f
Hallucinations
in dementia 374
in mental status examination 347-348
Halobetasol propionate 1247t
Haloperidol 332-333
aging effect on 61t
in agitation 356
sexual function and 1163t, 1164t
Hamilton Depression Rating Scale 314, 316t-318t, 345t, 350
Hammer toe 36, 553-554
Hampton's hump 775
Hand (see also Finger[s])
acroparesthesias of 535
cold 535
deformities of 536-540, 537f, 538f, 539f
disorders of 535-544
erosive osteoarthritis of 538
ischemia of 920-922, 921t
muscle cramps in 535-536
overuse syndromes of 536, 540-541
Raynaud's phenomenon of 922-923
surgery on 263
tendon disorders of 543-544, 544f
Hashimoto's disease 643, 644, 651, 653
Hayflick's limit (phenomenon) 5
H2 blockers
delirium with 352t
in esophagitis 1112
in gastrointestinal reflux disease 1040
in peptic ulcer disease 1046
sleep disorders with 451t
Head
in physical examination 28t, 34
trauma to
     parkinsonism with 444t
     subarachnoid hemorrhage and 416-417
     subdural hematoma with 421-423
     tinnitus with 1330t
tumors of, dysphagia with 1032, 1033
Headache
in ischemic stroke 403
subarachnoid hemorrhage and 417
subdural hematoma and 422
Health care funding 164-171 (see also Medicaid; Medicare)
Health care services
demographics of 21
Health maintenance organizations (HMOs) 164
Health risk appraisal 157f, 158-161
Hearing
evaluation of 33
loss of 1317-1328, 1317t
     acoustic neuroma and 1341
     assistive listening devices for 1326-1327
     classification of 1317-1318
     diagnosis of 1321f
     drug-associated 1367t-1371t
     hearing aids for 1322-1326, 1324f, 1324f, 1325f
     otosclerosis and 1339-1340
     psychosis and 309, 331
     rehabilitation after 1328
     resources on 1414-1415
     screening for 47t
     tinnitus and 1329, 1330t, 1332
Hearing aids 1322-1326, 1324f, 1324f, 1325f
Heart
age-related changes in 813, 814t-815t, 863, 896, 902
amyloid accumulation in 914
arrhythmias of (see Arrhythmias)
contractility of 816t, 817, 818-819, 821
coronary artery disease of (see Coronary arteries, disease of)
disease of (see also specific diseases)
     antidepressant use and 321
     depression and 311t
     driving and 235
     mortality rates for 12, 13t
     rehabilitation for 278-279, 280t
in hyperkalemia 571
in hypokalemia 568
idiopathic fibrosis of 896
imaging of 829-832
infarction of (see Myocardial infarction)
infection of (endocarditis) 878-885, 881t, 883t-884t
left ventricle of
     filling rate of 816, 817f
     hypertrophy of 824-825
murmurs 34
     in physical examination 34
in physical examination 34
in polymyositis 526
right ventricle of
     hypokinesis of 777
     surgery on 942-950, 945t
sounds 34
transplantation of 910
valves of
     disease of 863-877 (see also specific valvular diseases)
      in infective endocarditis 878
Heart block 895t, 898-899
idiopathic fibrosis and 896
pacemaker for 897
Heartburn 1039
Heart failure 40, 900-911
in acute aortic regurgitation 868
adverse drug interactions with 67t
anemia in 674-675
anesthesia effects of 260t
antihypertensives in 843t
in diabetes mellitus 626
driving and 235
etiology of 900-901, 901t
with hypernatremia treatment 568
in hyperthyroidism 649
postoperative 251
rehabilitation for 278-279, 280t
renal adenocarcinoma and 988
sexual activity in 1159
surgical outcome and 245
tertiary prevention in 51
Heart murmurs (see also Heart sounds)
in aortic regurgitation 868, 869-870
in aortic valve stenosis 865-866
in hypertrophic cardiomyopathy 912-913
in infective endocarditis 880
in mitral regurgitation 873, 875
in mitral stenosis 872
in physical examination 34
in tricuspid regurgitation 876-877
Heart rate
age-related changes in 816t, 819, 896
during exercise 821
for exercise 302, 302t
Heart sound(s) 34, 824 (see also Heart murmurs)
in aortic stenosis 865
fourth 817, 824
in heart failure 902
second, splitting of 824
third 824
Heat exhaustion 660
Heatstroke 660-663, 661t
Heat therapy 274-276
Heavy metal poisoning 438t
Heberden's nodes 36, 535
in osteoarthritis 490, 538
Heel, pain in 547t, 549t, 554-555
Helicobacter pylori infection
in gastric cancer 1137
in gastritis 1041
in peptic ulcer disease 1042-1043, 1047
vitamin B12 deficiency and 591
Heliotrope rash 525
Heller's procedure 1036
Hemangioma, hepatic 1148-1149
Hematocrit
age-related changes in 656t, 673
in deep vein thrombosis 923-924
in fracture evaluation 217
Hematologic disorders 674-714 (see also specific disorders)
in vitamin B12 deficiency 591-592
Hematologic system (see Blood)
Hematoma
intracerebral 418-421, 422t
subdural 421-423
     dementia with 371
     muscular symptoms in 516t
Hematuria 1193
in bladder cancer 992
renal adenocarcinoma and 988-989
Hemianopia
in stroke patient 283
Hemiballismus 430t
Hemicolectomy, in angiodysplasia 1058
Hemidystonia 412t
Hemiparesis 412t
Hemiparkinsonism 412t
Hemochromatosis 1072-1073
vitamin C effects in 594
Hemodialysis
in acute renal failure 962
anemia with 678
in chronic renal failure 963
Hemoglobin
age-related changes in 673
glycosylated (Hb A1c) 51, 629, 630
Hemolytic anemia 679-682, 680t
Hemorrhage (see also Bleeding)
bone marrow response to 672-673
esophageal 1109
fibrinolytic agent--related 701, 701t
gastrointestinal tract 1105-1112 (see also Gastrointestinal tract, bleeding from)
heparin-related 698
intracerebral 418-422, 419f, 420t, 421t
intracranial 416-421, 419f, 421t-422t
subarachnoid 416-418
thrombolytic-related 929
warfarin-related 699, 929
Hemorrhagic stroke 416-421, 419f, 421t-422t
Hemorrhoids 1074-1076
Heparin (see also Anticoagulants)
aging effect on 60t
in deep vein thrombosis 928
in disseminated intravascular coagulation 693
in ischemic stroke 410, 415
low-molecular-weight 695t, 698
     in hip fracture 216
after myocardial infarction 859
prophylactic
     in deep vein thrombosis 926
     in pulmonary embolism 778
in pulmonary embolism 777
sexual function and 1164t
unfractionated 695t, 697-698
in unstable angina 857
Hepatic (see Liver)
Hepatitis 1071-1072
hepatocellular carcinoma and 1149
vaccine against 1360t-1362t
Hepatocellular carcinoma 1149-1150
Hepatocytes 1004
Hernia
diaphragmatic 1119-1121
hiatus 1119-1120
inguinal 1121
paraesophageal 1120-1121
peritoneal and small bowel (enterocele) 1195
Richter's 1116
scrotal 1191
Heroin, sexual function and 1163t, 1164t
Herpes zoster infection 1258-1261, 1357, 1377t
oral 1018
tinnitus and 1330t
Hiatus hernia, sliding 1119-1120
Hill posterior gastropexy
in gastroesophageal reflux disease 1040
in hiatus hernia 1120
Hip
bursitis of 498
fracture of 224-228
     acetabular 225
     benzodiazepine use and 340
     femoral neck 224-225, 224f, 227-228, 228f
     intertrochanteric 225, 226f, 228, 229f
     low-molecular-weight heparin in 216
     nonsurgical treatment of 283-284
     rehabilitation for 283-284
     subcapital 224, 224f, 227-228, 227f
     venous thromboembolism prophylaxis for 695-696, 927
     warfarin in 215-216
range of motion of 270t
replacement of 227-228, 228f
     anesthesia for 262
     deep vein thrombosis after 927
     occupational therapy after 290
     pain after 264
     rehabilitation after 283
     therapy after 290
     venous thromboembolism prophylaxis for 694-695
Hirudin 700
Histamine 60t
Histamine-2 blockers (see H2 blockers)
History (see Patient history)
HIV infection 1379-1382, 1381t
dementia with 370
gastrointestinal tract infection in 1088
HMO (Health Maintenance Organization) 164
Hodgkin's disease 743-747, 745t, 746t, 747t
Hollenhorst plaque 1306
Homans' sign 215
Home assessment 52, 201t-203t
Home health care 87-90, 88t
pharmacist in 86
physician role in 87-88
reimbursement for 88-89, 166
resources on 1415
Homocysteine 593
atherosclerosis and 852, 917
Homosexuality 1157
social issues and 144
Hopkins Competency Assessment Test 345t, 350
Hoover's sign 787
Hordeola 1311
Hormone (see specific hormone)
Hormone replacement therapy 655-659, 656t (see also Estrogen replacement therapy)
Hospice care 90-91, 125, 723-724 (see also Dying patient)
funding for 123, 166
pharmacist in 86
resources on 1413
Hospital
day programs of 92
pharmacist in 85
Hospitalization 95-104
advance directives in 98
adverse drug reactions during 100-101
adverse effects of 96t
chaplain's role during 148
for COPD 782
deconditioning with 472
depression and 321-322
diabetes mellitus and 636
discharge planning in 96, 103-104
     legal issues of 140
ELDERS considerations during 97, 98t
falls and 102, 198
iatrogenic complications of 53
incontinence during 101
Medicare coverage for 165
mental status during 100
nursing care during 97
nursing home transfer for 104, 109
nutrition during 98-99
outcome of 95-96
physical restraints during 100
pneumonia during 758
rates of
     U.S. 16
rehabilitation during 102-103
skin care during 101-102
     utilization of
     U.S. 16
     world 22
venous thromboembolism during 693-697, 694t, 695t
Hot flashes 655, 1208-1209, 1211, 1216
Hot packs 275
Housing, supportive (see Assisted-living facilities)
Human immunodeficiency virus (HIV) infection 1378-1382, 1381t
gastrointestinal tract infection in 1088
Human papillomavirus (HPV)
in cervical cancer 1205-1206
genital infection with 1190
urethral tumors and 995
Humerus (proximal)
fracture of 222-223
Hungry-bone syndrome 575, 580
Hunner's ulcers 1188
Hutchinson-Gilford syndrome 8
Hutchinson's freckle 1278
Hyaluronic acid
in osteoarthritis 493
in photoaging 1238
Hydatid cysts 1129
Hydralazine
in heart failure 908
in hypertension 843t
Hydrocele 1191
Hydrocephalus
brain function in 382
normal-pressure 370
Hydrochlorothiazide
in hypertension 839t
Hydrocodone 387t
Hydrocolloid dressings 1271, 1273t
Hydrocortisone (see also Corticosteroids)
in pruritus ani 1074
in ulcerative colitis 1060, 1061t
in xerosis 1247t, 1248
Hydrocortisone sodium succinate, in thyroid storm 652
Hydrogels 1271, 1274t
Hydromorphone 387t, 391
Hydrophilic dressings, in pressure sore treatment 1273t
Hydrotherapy 275
alpha-Hydroxy acid 1248
Hydroxychloroquine
in rheumatoid arthritis 502
in systemic lupus erythematosus 504
25-Hydroxycholecalciferol, age-related changes in 573
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors 617, 618t-619t, 621
Hydroxyurea
in myelofibrosis 713
in polycythemia vera 710
in primary thrombocythemia 707
25-Hydroxyvitamin D3 (calcidiol)
in hypocalcemia 575
1,25-Hydroxyvitamin D3 (calcitriol)
in hypocalcemia 575
Hydroxyzine
adverse effects of 64t
in prostatitis 1189
Hyoscyamine
adverse effects of 65t
in diverticular disease 1055t
in irritable bowel syndrome 1070
Hyperalphalipoproteinemia 609t
Hyperamylasemia 1130
Hypercalcemia 576-580, 577t
in Paget's disease of bone 482
Hypercalciuria 576
in secondary osteoporosis 474f
Hypercapnia
in COPD 781, 785
ventilatory response to 756
Hypercholesterolemia 606, 608t (see also Lipoproteins, disorders of)
criteria for 611, 612t
diet in 614t, 615, 616t
postmenopausal 1210
secondary 607
treatment guidelines for 612-613
Hyperchylomicronemia 608t
Hypercoagulable states 689-693, 689t
Hypergastrinemia 1049
Hyperglycemia (see also Diabetes mellitus)
in diabetes mellitus 626
in nonketotic hyperosmolar syndrome 638
Hyperhomocysteinemia 690, 929-930
atherosclerosis and 852
Hyperinsulinemia 625
hypocalciuric, familial benign 578, 579
in multiple myeloma 734, 736-737
in secondary osteoporosis 474f
Hyperkalemia 570-571, 570t
age-related increase in 954
in renal failure 962
Hyperkinesia 430t, 431f
Hyperlipidemia, combined, familial 608t
Hyperlipoproteinemias 606-624, 608t-609t
screening for 50t
Hypermagnesemia 584
Hypernatremia 561, 566-568, 567t
Hyperostosis 488-489
Hyperparathyroidism 580
in acute renal failure 962
in chronic renal failure 964
clinical presentation of 38-39
hypercalcemia in 576, 577, 578
osteomalacia and 484
in Paget's disease of bone 481-482
Hyperphosphatemia 582
in chronic renal failure 964
Hyperprebetalipoproteinemia 608t
Hypersensitivity reaction
immunization-induced 1363
penicillin-induced 1367t
pneumonitis and 795t
Hypertension 833-844
adverse drug interactions with 67t
anesthesia effects of 260t
atherosclerosis and 834, 850
blood pressure measurement for 823
cardiovascular function and 821-822
classification of 838t
drug-induced 834
estrogen replacement therapy and 1215
heart failure in 900, 905
lacunar infarcts in 413
peripheral vascular resistance in 821-822
prevention of 51t
retinopathy with 838t
screening for 47t
sexual activity and 1160
surgery and 245
treatment of 70, 837-844, 838t, 839t, 840t, 841t, 842t, 842t, 843t, 843t
     risk stratification for 838t
white-coat 836
Hyperthermia 659-663, 661t
Hyperthyroidism 647-653, 649t
anxiety and 323t
clinical presentation of 38
muscular disorders in 529
screening for 47t
tremor in 438t
Hyperthyroxinemia, euthyroid 650
Hypertriglyceridemia 606 (see also Lipoproteins, disorders of)
diet in 615
familial 608t
mixed 609t
secondary 607
Hyperuricemia 494-496
during acute leukemia treatment 727
Hyperventilation syndrome 588
Hyperviscosity
in chronic leukemia 730
in multiple myeloma 735
in Waldenström's macroglobulinemia 735, 738, 739
Hypnotics (see Sedative-hypnotics)
Hypoalbuminemia 572
Hypoalphalipoproteinemia 609t, 615
Hypobetalipoproteinemia 609t
Hypocalcemia 573-576, 574t
in chronic renal failure 964
neuromuscular symptoms in 531
osteomalacia with 484
Hypochlorhydria 1000
vitamin B12 deficiency and 591
Hypochondriasis 319t, 328
anxiety and 323t
Hypogammaglobulinemia, in multiple myeloma 733-734
Hypogeusia 1027
Hypoglycemia 640t
anxiety and 323t
in diabetes mellitus 635-636
Hypoglycemics 73, 630, 632t, 635t
adverse effects of 65t
aging effects on 60t
combinations of 636
during exercise 305
Hypogonadism 1167, 1171-1174, 1172t
Hypokalemia 568-570, 569t
during acute leukemia treatment 727
adverse drug interactions with 67t
myopathy with 531-532
paralysis of 568
Hypomagnesemia 575, 583-584
neuromuscular symptoms in 531
Hyponatremia 561, 563-566, 565t
during acute leukemia treatment 727
adverse drug interactions with 67t
antidiuretic hormone secretion and 561
nutritional supplements and 564, 566
postoperative 253
Hypoparathyroidism 575
parkinsonism with 444t
Hypoperfusion, systemic 415-416
Hypophosphatemia 581-582
hypercalcemia and 579
hypocalcemia and 574
in osteomalacia 484, 485-486
Hypotension 844-849
angiotensin-converting enzyme inhibitor--induced 907
drug-related 846t, 847
in gastrointestinal tract bleeding 1107
with intubation 790-791
nitrate-induced 856
orthostatic 176, 845-848, 846t
     adverse drug interactions with 67t
     dizziness with 191t, 195
     during exercise 305
     in gastrointestinal tract bleeding 1107
     in multiple system atrophy 442
     in physical examination 31
     in stroke patient 282
     syncope with 174, 180
postoperative 251
postprandial 848-849
     dizziness with 191t
     syncope with 175, 180
with pulmonary embolism 773
tilt table therapy for 273
Hypothermia 659-663, 664t, 665f
intraoperative 262
postoperative 252
rewarming therapy for 668
Hypothyroidism 643-647
clinical presentation of 38
lipoprotein disorders with 607
muscular disorders in 529-530
nasal congestion in 1344
screening for 47t
subclinical 644, 645
Hypoxemia
in COPD 781, 785
postoperative 250
in respiratory failure 788-790
Hypoxia
ventilatory response to 756
Hysterectomy
sexual activity after 1162
vesicovaginal fistula after 1202
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.